CG
ICPT

Colony Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Colony Group’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-40
Closed -$6K – 688
2015
Q4 		$6K Hold
40
– – ﹤0.01% 646
2015
Q3 		$7K Hold
40
– – ﹤0.01% 654
2015
Q2 		$10K Hold
40
– – ﹤0.01% 599
2015
Q1 		$11K Hold
40
– – ﹤0.01% 564
2014
Q4 		$6K Hold
40
– – ﹤0.01% 641
2014
Q3 		$9K Hold
40
– – ﹤0.01% 614
2014
Q2 		$9K Buy
+40
New +$10.5K ﹤0.01% 541

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Colony Group's ICPT Position: Q1 2016 in Review

Colony Group sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2016, closing a stake of 40 shares — an estimated $6K sold.

Colony Group first reported a position in ICPT in Q2 2014 and held it in 7 quarters. The position peaked at $11K in Q1 2015. 160 funds tracked by Wall St. Rank hold ICPT as of Q1 2016.

  • Colony Group reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
  • Colony Group sold 40 Intercept Pharmaceuticals, Inc. shares in Q1 2016, an estimated $6K.
  • Colony Group first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2014 and held it in 7 quarters.
  • Colony Group's Intercept Pharmaceuticals, Inc. position peaked at $11K in Q1 2015.
  • 160 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2016.

Based on Colony Group's 13F filing for Q1 2016, filed 16 May 2016.